Brought to you by 
Nordic Capital sells, then re-buys Nycomed Holding
21 Apr 2005
Executive Summary
Investment bank Nordic Capital has entered into a definitive agreement to sell Nycomed Holding AS (the old Nycomed Pharma; pharmaceutical in-licensing and development) to a new investment company owned by CSFB Private Equity, Blackstone Capital Partners, and NIB Capital Private Equity. The purchase price is approximately $1.1bn, roughly 2 times Nycomed's 2001 sales, and is split evenly between debt and equity.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nordic Capital sells, then re-buys Nycomed Holding
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice